MMGT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.328600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.777800E-01
Normal-vs-Stage2
6.789400E-01
Normal-vs-Stage3
4.244600E-01
Normal-vs-Stage4
7.028100E-02
Stage1-vs-Stage2
5.860800E-01
Stage1-vs-Stage3
3.668100E-02
Stage1-vs-Stage4
7.795600E-02
Stage2-vs-Stage3
1.780580E-01
Stage2-vs-Stage4
4.989900E-02
Stage3-vs-Stage4
1.340450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.357200E-01
Normal-vs-AfricanAmerican
2.401000E-01
Normal-vs-Asian
8.651400E-01
Caucasian-vs-AfricanAmerican
1.068400E-01
Caucasian-vs-Asian
1.914240E-01
AfricanAmerican-vs-Asian
1.158380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.587600E-01
Normal-vs-Female
5.990800E-01
Male-vs-Female
7.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.035200E-01
Normal-vs-Age(41-60Yrs)
3.009000E-01
Normal-vs-Age(61-80Yrs)
8.379800E-01
Normal-vs-Age(81-100Yrs)
9.546000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.771000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.626000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.265200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.498900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.457700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.476200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.572800E-01
Normal-vs-Daily Drinker
9.878000E-01
Normal-vs-Weekly Drinker
9.046000E-01
Normal-vs-Occasional Drinker
2.544800E-01
Normal-vs-Social Drinker
6.016000E-01
Non Drinker-vs-Daily Drinker
9.323000E-01
Non Drinker-vs-Weekly Drinker
9.107000E-01
Non Drinker-vs-Occasional Drinker
1.180100E-02
Non Drinker-vs-Social Drinker
2.059200E-01
Daily Drinker-vs-Weekly Drinker
8.522600E-01
Daily Drinker-vs-Occasional Drinker
1.818330E-02
Daily Drinker-vs-Social Drinker
2.498400E-01
Weekly Drinker-vs-Occasional Drinker
2.570500E-02
Weekly Drinker-vs-Social Drinker
2.541400E-01
Occasional Drinker-vs-Social Drinker
3.931400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.482610E-01
Normal-vs-Grade 2
3.545900E-02
Normal-vs-Grade 3
3.553900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.744400E-01
Grade 1-vs-Grade 3
7.999200E-01
Grade 1-vs-Grade 4
1.482610E-01
Grade 2-vs-Grade 3
7.123800E-01
Grade 2-vs-Grade 4
3.545900E-02
Grade 3-vs-Grade 4
3.553900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.794200E-01
Normal-vs-NonDiabetic
6.979400E-01
Diabetic-vs-NonDiabetic
4.297200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.005400E-01
Normal-vs-NoPancreatitis
6.813400E-01
Pancreatitis-vs-NoPancreatitis
6.399200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.060800E-01
Normal-vs-N1
6.629000E-01
N0-vs-N1
7.705800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.166000E-01
Normal-vs-TP53-NonMutant
5.428800E-01
TP53-Mutant-vs-TP53-NonMutant
5.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
